GlassScriptPhysician profile
Cynthia O Field
NPI 1982634937
$719.10
in general payments reported to CMS, 2019-2025
8 companies · $29.58 in 2025
The $29.58 reported for 2025 was less than what a typical Developmental - Behavioral Pediatrics provider received nationally (typical 2025 total: $79.84).
See the full distribution for Developmental - Behavioral Pediatrics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $29.18 · 2021: $247 · 2022: $185 · 2023: $80.00 · 2024: $43.19 · 2025: $29.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $447.00 | 2021-2025 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $98.91 | 2019-2021 | |
| Corium, LLC | $55.15 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $44.20 | 2019-2023 | Jornay Pm |
| Tris Pharma INC | $29.93 | 2020-2025 | Dyanavel Xr |
| Rhodes Pharmaceuticals L.P. | $16.27 | 2019 | |
| Shire North American Group INC | $13.84 | 2019 | |
| Neos Therapeutics, LP | $13.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.